Solid Tumor Translational Research
Solid Tumor Translational Research website home page. Learn more at STTRCancer.org.
Dr. Eric Holland launched the Solid Tumor Translational Research (STTR) network to pursue new therapies for tumors affecting nearly a dozen major organs. The network’s goal is to translate new discoveries into lifesaving treatments.
The effort brings together investigators and clinicians from Fred Hutch, UW Medicine and Seattle Cancer Care Alliance. The effort is currently focused on developing precision treatments for tumors affecting the brain, breast, colon, head and neck, lung, ovary, pancreas and prostate. Holland plans to bolster research in these areas until they are all substantial enough to earn SPORE grants, which help researchers translate discoveries into therapies.
Desert Horse-Grant, director for strategic planning and operations, and Dr. Eric Holland, director for Solid Tumor Translational Research
STTR sets the stage for the type of collaborations that flourished under Holland at Memoprial Sloan-Kettering, where he invited researchers from multiple disciplines to work together. Together, scientists will provide insights into how to improve treatment for many tumors and will lead to discoveries that can then be applied back to brain cancer. It’s the best shot at making headway against the disease.
“It will take collaborations with computer scientists, software programmers, nanotechnology engineers and others to make the next level of discoveries,” said Desert Horse-Grant, who directs STTR’s strategy and operations. “If we can integrate disciplines and feed the information into high-powered computers, it could lead to the breakthroughs that have eluded us.”
Visit the Solid Tumor Translational Research website to learn more and to see who is involved. Share your comments and stories at STTR Twitter, Facebook and Pinterest.